Skip to main content

Membranous Labyrinth Distension Seen in MRI of Meniere Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on July 2, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 2, 2024 -- Distension of the membranous labyrinth is seen in histologic specimens from deceased patients with symptoms consistent with Meniere disease and in magnetic resonance imaging (MRI) from patients exhibiting classic Meniere disease symptoms, according to a study published online June 13 in the Ear, Nose & Throat Journal.

Eugene D. Ark, from the College of Medicine at the University of Illinois-Chicago, and colleagues explored the distended membranous labyrinth through a comparison of early temporal bone studies with contemporary magnetic resonance imaging techniques. Histopathological photomicrographs from deceased patients with symptoms consistent with Meniere disease were reviewed, and MRI sequences were captured from patients exhibiting classic Meniere disease symptoms four hours after gadolinium administration.

The researchers found that in patients with Meniere disease, both histopathologic examination and MRI imaging revealed consistent distention of the saccule, utricle, and scala media. The correlation between postmortem histological findings and MRI evidence of distension in living patients was successfully demonstrated.

"This study's overall aim is to raise public awareness that these neglected collections are valuable and should be curated," the authors write. "This article demonstrates the correlation of traditional histopathologic findings with the MRI-demonstrated distention of the endolymphatic spaces."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.